|Podcasts|February 7, 2023
The Rewarding Path Of Science
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Sean Bohen, CEO of Olema Oncology, discusses his career and significant contributions to the clinical research and development of numerous oncology drugs that received regulatory approval for various indications. Plus a look at Olema, how they operate, and challenges they face.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
Operational Pragmatism in ePRO-heavy trials
3
How Selective Safety Data Collection Could Make Pragmatic Trials Scalable
4